Characterization of Staphylococcus aureus infections in children with Down syndrome

Jeffrey N Johnston1, Sheldon L Kaplan1, Edward O Mason1

  • 1Texas Children's Hospital, Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, United States.

Insights

Staphylococcus aureus infections in children with Down syndrome (DS) are often skin or ear infections, with a high rate of MRSA. Recurrent ear infections showed resistance to antiseptics and fluoroquinolones.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genetics

Background:

  • Staphylococcus aureus infections in individuals with Down syndrome (DS) are not well-understood.
  • Characterizing these infections is crucial for appropriate clinical management and public health strategies.

Purpose of the Study:

  • To determine the clinical and molecular characteristics of Staphylococcus aureus infections in children with Down syndrome.
  • To identify specific resistance patterns and virulence factors in S. aureus isolates from this population.

Main Methods:

  • Retrospective review of medical records for children with DS and S. aureus infections from 2001-2011.
  • Molecular characterization of isolates including antimicrobial susceptibility, pulsed-field gel electrophoresis, and detection of resistance genes (pvl, mupA, smr) and SCCmec type.

Main Results:

  • 34 S. aureus infections in 26 children with DS were identified; 61% were MRSA.
  • Skin and soft tissue infections (SSTI) were most common (17/26), followed by ear infections (7/26).
  • Recurrent ear infections (5/8) were associated with antiseptic (smr+) and fluoroquinolone resistance genes.

Conclusions:

  • S. aureus infections in DS patients present similarly to other groups, but with a higher prevalence of ear infections.
  • Ear isolates frequently carried antiseptic and fluoroquinolone resistance genes, highlighting a potential challenge in treatment.
  • Further research with larger cohorts of DS patients is needed to validate these findings.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
72
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
40
Karyotyping01:17

Karyotyping

Overview
70.1K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
46
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
111
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K